Using text messages to remind patients to complete colon cancer screening tests
Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the New York University (NYU) Family Health Centers (FHCs)
This study is testing whether sending text message reminders can help adults aged 45 to 75 complete their colon cancer screening tests better than phone calls.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 764 (estimated) |
| Ages | 45 Years to 75 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06632054 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of targeted text message reminders compared to traditional phone call reminders in increasing the completion rates of fecal immunochemical tests (FIT) for colon cancer screening among patients at NYU Family Health Centers. The study will focus on adult patients aged 45 to 75 who are eligible for FIT. By analyzing the response rates to these different reminder methods, the research seeks to identify the most effective approach to enhance screening compliance.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 45 to 75 who are eligible for fecal immunochemical testing at a Family Health Center clinic.
Not a fit: Patients outside the age range of 45 to 75 or those not eligible for FIT will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve colon cancer screening rates, leading to earlier detection and better patient outcomes.
How similar studies have performed: Previous studies have shown that text message reminders can effectively increase patient compliance in various health screenings, suggesting a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (ages 45-75) eligible for FIT at a Family Health Center clinic (excluding Flatbush locations). Exclusion Criteria: * See inclusion criteria.
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Leora Horwitz, MD, MHS — NYU Langone Health
- Study coordinator: Olivia Korostoff-Larsson
- Email: Olivia.korostoff-larsson@nyulangone.org
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.